Accordingly, LRG1 has been shown to be induced in patients with age-related macular degeneration [27], diabetic retinopathy [28], diabetic kidney disease [18], cancer [22,29,30,31], and cerebrovascular disease [32,33]. Here, LRG1 is linked to cancer.